Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-10-23Clinical Trial Update: Intravascular Ultrasound Evaluation of Renal Nerves in Different Diseases
A clinical trial evaluating renal nerve characteristics using intravascular ultrasound in hypertension and heart failure. The study status i…
-
FDA approval · 2014-10-22FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a generic spironolactone and hydrochlorothiazide combination product from Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension [Phase 3]
Phase 3 trial assessing the efficacy and safety of telmisartan versus losartan in adults with primary hypertension. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions [NA]
Clinical trial update on a study evaluating medical assistant health coaching in primary care for patients with chronic conditions (diabetes…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Screening for Abdominal Aortic Aneurysm and Abdominal Aortic Atherosclerosis by Hand-Held Ultrasonography [NA]
This clinical trial update notes the completion of a study screening for abdominal aortic aneurysm and abdominal aortic atherosclerosis usin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension [Phase 4]
A Phase 4 clinical trial compared lercanidipine hydrochloride (Zanidip) with felodipine sustained-release for hypertension; the study has co…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin [Phase 1]
Phase 1 study comparing pharmacokinetics and safety of a Fimasartan/Rosuvastatin fixed-dose combination tablet versus coadministration in hy…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets [Phase 1]
Phase 1 study comparing the pharmacokinetics of a fixed-dose combination tablet of fimasartan/amlodipine with the coadministration of fimasa…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish [NA]
This update summarizes a completed clinical trial investigating the health effects of a Nordic diet rich in plant-based foods and fish on in…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)
A completed post-marketing surveillance study sponsored by Boehringer Ingelheim in rehabilitation clinics to monitor safety related to hyper…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)
This document reports the completed PROTEKT program evaluating telmisartan (Micardis/MicardisPlus) for therapy optimization in cardiovascula…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Telmisartan in Mild to Moderate Hypertensive Patients [Phase 4]
Clinical trial update reporting a completed Phase 4 study of telmisartan for mild to moderate hypertension, sponsored by Boehringer Ingelhei…
-
CLINICAL_TRIALS research · 2014-10-09Clinical Trial Update: Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.
Clinical trial update investigating nocturnal blood pressure and its relationship to hypertension using central and peripheral 24-hour measu…
-
FDA approval · 2014-10-07FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2014-10-06Clinical Trial Update: Improved Delivery of Cardiovascular Care Through Outreach Facilitation [Phase 1]
Phase 1 clinical trial update on improving delivery of cardiovascular care through outreach facilitation; the study status is completed and …
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Hypertension of Our Patients: Knowledge, Control, Comorbidity
This report summarizes a completed clinical trial focused on hypertension in patients, examining knowledge, blood pressure control, and rela…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study [NA]
A completed pilot trial evaluating the efficacy and safety of the DASH diet in adults with moderate chronic kidney disease.
-
CLINICAL_TRIALS research · 2014-10-02Clinical Trial Update: Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients [Phase 4]
This clinical trial update describes a Phase 4 study examining the effects and underlying mechanism of a lipid-lowering intervention for vas…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: RCT Examining Effects of Probiotics in T2DM Individuals [NA]
This entry notes a randomized clinical trial evaluating the effects of probiotics in individuals with Type 2 Diabetes Mellitus and related c…
-
FDA label_change · 2014-09-30FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries [Phase 3]
Phase 3 trial evaluating the effect of fish oil (omega-3 fatty acids) on arterial health was terminated, with results posted in 2014.
-
FDA approval · 2014-09-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amlodipine besylate submitted by Aurobindo Pharma Limited.
-
FDA approval · 2014-09-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for amlodipine besylate, authorizing changes to an existing product's approval.
-
FDA label_change · 2014-09-26FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for carvedilol submitted by Glenmark Pharmaceuticals USA, resulting in changes to the drug’s lab…
-
FDA approval · 2014-09-26FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for RAMIPRIL from Hikma Pharmaceuticals USA Inc. under ANDA077900.